ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 404 filers reported holding ENCOMPASS HEALTH CORP in Q1 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $12,747,000 | -5.7% | 155,636 | -4.8% | 0.01% | 0.0% |
| Q4 2020 | $13,520,000 | +29.0% | 163,506 | +1.4% | 0.01% | +11.1% |
| Q3 2020 | $10,478,000 | -19.6% | 161,242 | -23.4% | 0.01% | -25.0% |
| Q2 2020 | $13,030,000 | -24.3% | 210,399 | -21.8% | 0.01% | -36.8% |
| Q1 2020 | $17,223,000 | -28.7% | 268,977 | -23.0% | 0.02% | -5.0% |
| Q4 2019 | $24,148,000 | +41.4% | 349,168 | +29.4% | 0.02% | +33.3% |
| Q3 2019 | $17,079,000 | -8.5% | 269,896 | -8.4% | 0.02% | -6.2% |
| Q2 2019 | $18,674,000 | +20.7% | 294,729 | +11.3% | 0.02% | +14.3% |
| Q1 2019 | $15,469,000 | -23.2% | 264,882 | -18.8% | 0.01% | -30.0% |
| Q4 2018 | $20,131,000 | -36.5% | 326,269 | -19.7% | 0.02% | -25.9% |
| Q3 2018 | $31,685,000 | +1056066.7% | 406,475 | +967697.6% | 0.03% | – |
| Q2 2018 | $3,000 | 0.0% | 42 | -12.5% | 0.00% | – |
| Q1 2018 | $3,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |